Updated Story HHS Deputy Chief of Staff for Policy Paul Mango told Inside Health Policy the government is buying additional lots of COVID-19 antibody candidates so that it will have enough antibody drugs to give away until vaccines are available. Later in the day, HHS announced a $486 million contract with AstraZeneca to test and make an antibody cocktail that is entering phase 3 clinical trials. “We have engaged in a number of contracts for procurement...